Skip to main content
OpenTrials

Clinical trial condition

Chronic Spontaneous Urticaria

Explore clinical trials studying Chronic Spontaneous Urticaria. Study availability and eligibility vary by location and protocol.

69 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Chronic Spontaneous Urticaria trial results

Completed

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

NCT04833855

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Avance Clinical Trials Laguna Niguel, California, United States
  • Jonathan Corren MD Inc Los Angeles, California, United States
View all 81 locations
View Trial Details
Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

NCT05030311

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site North Little Rock, Arkansas, United States
  • Novartis Investigative Site Bakersfield, California, United States
  • Novartis Investigative Site Lancaster, California, United States
View all 112 locations
View Trial Details
Completed

A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

NCT05048342

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Urayasu, Chiba, Japan
  • Novartis Investigative Site Izumiōtsu, Osaka, Japan
  • Novartis Investigative Site Neyagawa, Osaka, Japan
View all 13 locations
View Trial Details
Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

NCT05032157

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Little Rock Allergy and Asthma Clnc Little Rock, Arkansas, United States
  • Allergy and Asthma Medical Group and Research Center San Diego, California, United States
View all 122 locations
View Trial Details
Completed

A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

NCT05368285

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama dba Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Little Rock Allergy & Asthma CRC Little Rock, Arkansas, United States
  • Kern Research, Inc Bakersfield, California, United States
View all 56 locations
View Trial Details
Completed

A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines

NCT03907878

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Ichikawa, Chiba, Japan
  • Novartis Investigative Site Obihiro, Hokkaido, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Nishinomiya, Hyōgo, Japan
View Trial Details
Completed

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

NCT03580356

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Resch of Arizona-Div of Allergy Asthma and Immunology Scottsdale, Arizona, United States
  • Atria Clinical Research Asthma and Allergy Institute Little Rock, Arkansas, United States
  • DeMera Allergy Asthma and Immun Ctr Fresno, California, United States
View all 183 locations
View Trial Details
Completed

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

NCT05960708

Conditions
Allergic Disease, Chronic Disease, Chronic Inducible Urticaria, +13 more
Locations
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View Trial Details
Completed

A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria

NCT05335499

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Fukuoka, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Gunma, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hiroshima, Japan
View Trial Details
Completed

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

NCT05107115

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Investigational Site Number : 0320006 CABA, Buenos Aires, Argentina
  • Investigational Site Number :0320006 CABA, Buenos Aires, Argentina
  • Investigational Site Number : 0320002 CABA, Buenos Aires, Argentina
  • Investigational Site Number :0320002 CABA, Buenos Aires, Argentina
View all 128 locations
View Trial Details

Related conditions